Search
Now showing items 1-6 of 6
The development of novel polymeric delivery systems for the controlled release of therapeutic agents to prevent the spread of zoonotic diseases
(2022)
The potential for zoonotic transmission - a disease transmitted from animals to people
- of many disease pathogens is a significant concern worldwide. It is estimated that
60 of human emerging infectious diseases, including ...
Antimicrobial films containing green synthesised zinc oxide nanoparticles for biomedical applications
(Athlone Institute of Technology, 2020-06)
Synthetic biomaterials have been vastly investigated for
different biomedical applications such as wound healing
adhesives, implant devices and drug delivery systems. The
effort on this field of study promoted the ...
Development of biphasic drug delivery PVA/propolis electrospun nanofibres
(Athlone Institute of Technology, 2020-06)
The integration of nanotechnology into biomedical applications is called “nanomedicine”. Nanomedicine has the ability to change properties of materials at the molecular and atomic level [1]. Numerous methods have been ...
Development of novel PVA-based nanoparticles for delivery system for bone cancer applications
(Athlone Institute of Technology, 2020-06)
Osteosarcoma is one of the most frequent bone cancers with almost 30% of patients developin metastasis [1,2]. Further study is needed to develop new drugs that avoid metastasis. There is experimental evidence that chalcones, ...
Smart hydrogels: therapeutic advancements in hydrogel technology for smart drug delivery applications.
(Wiley, 2015-12)
Hydrogels are a fusion of solid and liquid phases which closely mimic biological tissue. As such they have enormous potential for drug delivery systems as they are biocompatible and may be tailored to specific applications. ...
"My heart, your heart"; hot melt enteric targeted therapeutic delivery platform: enhancing drug solubility through advanced polymer extruded drug delivery system
(Athlone Institute of Technology, 2020-06)
Cardiovascular diseases (CVDs) are the number 1 cause
of death globally. Fenofibrate has been shown an
excellent treating effect on CVDs. However, Fenofibrate
is a neutral, lipophilic compound that is practically
insoluble ...